03-05-2023 : 769 Pharmacists work as Medical Representative, of which 39 work as Senior Medical Representative * 02-06-2020 : 216 non Pharmacists work as Medical Representative, and 54 work as Senior Medical Representative * 05-06-2023 : In Lebanon, 88 generic medicinal products are more expensive than their Originators * 31-12-2019 : A medicinal product refused in Europe is marketed in Lebanon * 05-06-2023 : At least 332 medicinal products are available on the Lebanese market and are not available in the country of origin * 05-06-2023 : The price of the most expensive medicine available in Lebanon is 30434557 LL * 05-06-2023 : At least 1309 medicinal products are more expensive in Lebanon than in the countries of origin * 01-01-2019 : Daktavira, a generic of Daklinza, is registered in Lebanon but has no public price * 31-12-2019 : 352 medicinal products have been declared as non-marketed or withdrawn * 09-11-2021 : 64.72% of lebanese pharmacists are female * 31-12-2019 : 486 medicines were submitted to the Ministry of Health for a marketing authorization, and 514 medicines were registered to date * 15-06-2018 : The Minister of Public Health, has decided to suspend the commercialization of AB Slim (Ab Care Medical Herbs), which contains sibutramine, sildenafil and phenolphthalein * 01-06-2020 : Some Non-Marketed medicines are still imported * 01-06-2020 : Ixempra, a medicinal product withdrawn in Europe is imported to lebanon * 01-06-2020 : A vaccine made in India, removed from WHO list of prequalified vaccines, is submitted for registration in Lebanon * 01-06-2020 : Lebanon has 14 CROs, and is ranked as one of the largest countries in the world in clinical studies. According to the WHO, 817 clinical studies are currently conducted in Lebanon. * 05-01-2021 : * 01-10-2023 : Adakveo is now withdrawn from use in the European Union due to lack of therapeutic efficacy *
Ritomune* : | |
Type | Medicine Non Marketed |
Originator | Norvir° |
Agent | Droguerie de l'Union |
Distributor | Droguerie de l'Union |
Laboratory | Cipla |
Responsible Party | Cipla Ltd |
Origin | India |
Manufacturer | Cipla Ltd |
Manufacturing Type | G |
Origin | India |
ATC | J05AE03 |
Ritomune* :
Ritomune* :
Ritomune* :
Ritomune* :
Ritomune* :
Frequency | Percentage |
---|---|
Very Common | ≥ 1/10 |
Common | ≥ 1/100 - < 1/10 |
Uncommon | ≥ 1/1,000 - < 1/100 |
Rare | ≥ 1/10,000 - < 1/1,000 |
Very Rare | < 1/10,000 |
Unknown | Cannot be Estimated |
Effect | Frequency |
---|---|
Abdominal pain | Very Common |
Abdominal pain lower | Very Common |
Abdominal pain upper | Very Common |
Acne | Common |
Acute kidney injury | Not known |
ALT increased | Common |
Amylase increased | Common |
Anaphylactic reactions | Rare |
Anxiety | Common |
Arthralgia (Pain joint) (Joint ache) | Uncommon |
AST increased | Common |
Asthenia | Very Common |
Autoimmune disorder | Not known |
Back pain | Uncommon |
Basedow's disease | Not known |
Blood alkaline phosphatase increased | Not known |
Blood bilirubin increased | Common |
Blood creatine phosphokinase increased | Uncommon |
Blood creatinine increased | Uncommon |
Blood glucose increased | Not known |
Blood magnesium increased | Not known |
Body fat disorder | Not known |
Breast enlargement | Not known |
Confusional state | Common |
Cough | Very Common |
Decreased appetite | Common |
Dehydration | Common |
Diabetes mellitus | Uncommon |
Diarrhoea (Diarrhea) | Very Common |
Disturbance in attention | Common |
Dizziness | Very Common |
Dysguesia (taste perversion) (Taste abnormality) (Taste disturbance) | Very Common |
Dyspepsia | Very Common |
Eosinophil count increased | Common |
Face oedema | Common |
Facial wasting | Not known |
Fatigue | Very Common |
Flatulence | Common |
Flushing | Very Common |
Gastroduodenal haemorrhage | Common |
Gastrooesophageal reflux disease | Common |
Gout | Common |
Haemoglobin decreased | Common |
Headache | Very Common |
Hepatitis | Common |
Hypercholesterolaemia | Common |
Hyperglycaemia | Rare |
Hyperlactacidaemia | Not known |
Hypersensitivity | Common |
Hypertension | Common |
Hypertriglyceridaemia | Common |
Hyperuricaemia | Not known |
Hypotension | Common |
Immune reconstitution inflammatory syndrome | Not known |
Insomnia | Common |
Insulin resistance | Not known |
Jaundice | Common |
Leukocyte count decreased (White blood cell count decreased) | Common |
Lipodystrophy acquired | Common |
Lipohypertrophy | Not known |
Lyell Syndrome (Toxic epidermal necrolysis) | Rare |
Maculopapular rash | Very Common |
Menorrhagia | Not known |
Micturition disorder | Uncommon |
Mouth ulceration | Common |
Myalgia | Uncommon |
Myocardial infarction | Uncommon |
Myopathy | Uncommon |
Myositis | Uncommon |
Nausea | Very Common |
Neuropathy peripheral | Very Common |
Neutrophil count decreased | Common |
Neutrophil count increased | Uncommon |
Oedema | Common |
Oedema peripheral | Common |
Oliguria | Uncommon |
Oropharyngeal pain | Very Common |
Orthostatic hypotension | Common |
Osteonecrosis | Not known |
Pancreatitis | Common |
Paraesthesia (paresthesia) | Very Common |
Paraesthesia oral | Very Common |
Peripheral coldness | Common |
Pharyngitis | Very Common |
Pruritus | Very Common |
Pyrexia | Common |
Rash erythematous | Very Common |
Renal impairment | Uncommon |
Rhabdomyolysis | Uncommon |
Seizures | Common |
Sensation of heat (Feeling of warmth) (Sensation of warmth) | Very Common |
Skin rash | Very Common |
Stevens-Johnson syndrome | Rare |
Syncope | Common |
Thrombocytopenia (Thrombopenia) | Common |
Thyroxine decreased | Common |
Thyroxine free decreased | Common |
Urticaria | Common |
Vision blurred | Common |
Vomiting | Very Common |
Weight decreased (Weight loss) | Common |
NB : Products With Same Indication |
Different Units By MoH Code
Ritomune* MoH 6292 :
Form | Capsule, hard |
Package Size | Box of 60 |
Strength | 100mg |
NSSF | ✘ |
Quarantine | ✘ |
Reg. Number | 221324/08 |
Submission date | 01/01/2008 |
Registration Year | 2011 |
Archived Date | 2018 |
Price Comparison
You have to register to view this info
Drop File